Amesite Executes Trading Partner Agreement Enabling Secure Connectivity with Leading Homecare Technology Platform
MWN-AI** Summary
Amesite Inc. (Nasdaq: AMST), a prominent player in the AI-driven healthcare technology sector, announced a significant collaboration on March 26, 2026, securing an Electronic Transactions Trading Partner Agreement with a leading homecare technology platform. This alliance positions Amesite's NurseMagic™ platform as a compliant healthcare data submitter, adhering to HIPAA and other regulations. NurseMagic™ is designed to streamline electronic visit verification (EVV) processes by connecting with essential electronic transaction infrastructures, utilizing standardized formats mandated by the Centers for Medicare & Medicaid Services (CMS).
The agreement allows NurseMagic™ to efficiently transmit and receive EVV transactions, enabling integration into existing operational frameworks for homecare providers without disrupting their compliance processes. Amesite's CEO, Dr. Ann Marie Sastry, emphasized NurseMagic™'s role as an AI-first electronic medical record (EMR) solution tailored for non-acute care. This development showcases Amesite's commitment to innovation within a $1.55 trillion market encompassing skilled nursing, home health, hospice, and senior living sectors.
Additionally, the announcement follows a series of positive financial milestones for Amesite, including a 69% quarterly revenue increase in Q2 2026. Customer feedback underscores NurseMagic™'s value, with users citing enhanced competitiveness, the ability to manage complex cases, and cost-effective, compliant documentation.
Amesite’s technological advancements reflect its strategic approach, aiming to provide a superior workspace that maintains operational integrity while transforming care workflows with AI capabilities. The NurseMagic™ platform, used by over 130 professions across the globe, affirms Amesite's position as an innovator in healthcare technology. With ongoing regulatory compliance and growing enterprise demands, Amesite remains poised for expansion in the non-acute care market.
MWN-AI** Analysis
In the rapidly evolving healthcare technology landscape, Amesite Inc. (Nasdaq: AMST) has positioned itself as a formidable player through its AI-native NurseMagic™ platform. The recent announcement of a Trading Partner Agreement with a leading homecare technology provider marks a significant milestone, establishing Amesite as a compliant electronic transaction submitter. This integration not only enhances NurseMagic™’s functionality in electronic visit verification (EVV) but also solidifies its appeal amongst home care agencies navigating the complex landscape of CMS compliance.
Investors should note key factors as they evaluate Amesite's market trajectory. The healthcare sector, particularly non-acute care, represents a lucrative market exceeding $1.55 trillion, with growing demand for AI-enhanced solutions. The successful integration of NurseMagic™ into existing homecare workflows positions Amesite to capture market share by alleviating compliance burdens while enhancing service efficiency.
Recent financial performance signals strong growth, marked by a remarkable 69% quarter-over-quarter revenue increase in Q2 2026. This momentum, alongside the recognition of NurseMagic™ as a finalist for Nurse.org’s “Best of Nursing: AI Nursing Tool” award, bolsters confidence in the platform's market readiness. Customer testimonials underscore the platform's ability to streamline operations, reduce costs, and improve compliance—a critical factor for uptake in the competitive homecare technology market.
However, potential investors should remain cautious of risks inherent in the healthcare sector, including regulatory changes and rapid technological advancements. As Amesite continues to navigate these challenges, its committed adoption of a disciplined, infrastructure-first approach will be essential in maintaining growth momentum. The combination of strong current performance and a scalable, innovative product indicates that Amesite may provide promising long-term investment opportunities as it capitalizes on emerging trends in healthcare technology.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
DETROIT, March 26, 2026 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasdaq: AMST), developer of the AI?native NurseMagic™ platform and EMR for non?acute care, today announced that it has entered into an Electronic Transactions Trading Partner Agreement with a leading homecare technology platform company, that processes tens of billions of dollars in homecare services annually. The Agreement establishes Amesite as a compliant trading partner, in accordance with HIPAA and applicable regulations.
Under the Agreement, Amesite is authorized to securely connect NurseMagic™ to a leading electronic transaction infrastructure as a healthcare data submitter. This integration allows NurseMagic™ to streamline critical electronic visit verification (EVV) by leveraging standardized formats mandated by Centers for Medicare & Medicaid Services (CMS) and the 21st Century Cures Act, widely used by homecare providers nationwide. Furthermore, the Agreement enables NurseMagic™ to transmit and receive these transactions for providers, allowing organizations using the larger homecare technology platform to integrate NurseMagic™’s AI-powered workflows into their daily operations without changing the way that their EVV compliance function works.
Amesite CEO Dr. Ann Marie Sastry said, “We believe we are the first company to deliver an AI-first EMR solution for non-acute care: a major advancement in a roughly $1.55 trillion market spanning skilled nursing, home care, home health, senior living, hospice and private pay. This integration is important evidence that our disciplined, infrastructure-first approach is working. Our customers can integrate mandated technologies like EVV through the familiar channels they already use, with NurseMagic™’s AI-first infrastructure—that performs like moving from DSL to gigspeed fiber without changing your router. NurseMagic™ delivers a radically simplified, AI-first workspace, with single-source-of-truth records and workflows organized for machines as well as people, enabling transformative AI to entire businesses seamlessly, compliantly and at scale.”
Amesite Senior AI Manager, Sai Nittala said, “EVV is an example of a regulatory function already managed by scaled, incumbent platforms whose compliance infrastructure we can leverage to mutual benefit. As an innovator in healthcare AI, we take on the most complex parts of care workflows, turning information no human can realistically integrate at scale into clear, usable documentation through our AI infrastructure. By connecting NurseMagic™ into the systems agencies already rely on for CMS compliance, we enable standard interfaces to handle routine processes while our native AI capabilities focus on transforming the quality, speed, and efficiency of the work itself.”
The market’s positive signals to NurseMagic™’s innovative platform are exemplified by NurseMagic™ being named a finalist for Nurse.org’s “Best of Nursing: AI Nursing Tool” award and recognition of Amesite’s CEO as a Commercial Excellence Honoree by McKnight’s. Customer testimonials praise multiple dimensions of the platform, including how it is a “must-have” to stay competitive, enables them to handle more medically complex clients, saves money and time, and creates documentation that complies with CMS review.
This announcement follows a series of milestones for Amesite, including the launch of its AI?native NurseMagic™ EMR for non?acute care, a 69% QoQ revenue increase in Q2 2026, and a 63% revenue growth following the launch of its census-based Enterprise subscription model. These milestones build on previously announced quarterly revenue increase of 140%, expanded enterprise offerings due to customer demand, and full HIPAA compliance, positioning Amesite to pursue significant opportunities in the non?acute care markets.
About Amesite Inc.
Amesite (NASDAQ: AMST) is an AI-driven software company focused on delivering technology platform solutions. Its flagship product, NurseMagic™, is designed to streamline clinical documentation, support point-of-care decision-making, and deliver actionable operational insight, and has expanded from an assistant for individual clinicians into an enterprise platform that includes an electronic medical record (EMR) offering. NurseMagic™ is used by used by over 130 professions across all 50 states and over 20 countries. Built on proprietary AI and designed to meet applicable regulatory and security requirements, the platform serves B2B and B2C users with capabilities that include workflow integration and multilingual support.
Forward-Looking Statements
This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company, the Company's planned online machine learning platform, the Company's business plans, any future commercialization of the Company's online learning solutions, potential customers, business objectives and other matters. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its planned platform are set forth in the Company's filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.
Sources
- https://www.grandviewresearch.com/industry-analysis/us-skilled-nursing-facility-market
- https://www.ibisworld.com/united-states/industry/home-care-providers/1579/
- https://www.grandviewresearch.com/industry-analysis/us-home-healthcare-market-report
- https://www.grandviewresearch.com/industry-analysis/us-senior-living-market-report
- https://www.grandviewresearch.com/industry-analysis/us-hospice-market
- https://www.aaltci.org/news/long-term-care-insurance-news/out-of-pocket-expenditures-for-nursing-home-care-expenditures-to-grow
FAQ**
How does the Electronic Transactions Trading Partner Agreement affect Amesite Inc. AMST's position in the competitive homecare technology market, particularly regarding compliance and efficiency?
What specific advantages does the AI-native NurseMagic™ platform offer to healthcare providers when integrated with the existing systems of Amesite Inc. AMST's homecare technology partner?
Considering the recent 69% QoQ revenue increase, what are Amesite Inc. AMST's strategies to sustain this growth momentum in the non-acute care market moving forward?
How does Amesite Inc. AMST plan to leverage the recognition received for NurseMagic™ to attract new clients and solidify its reputation in the healthcare technology sector?
**MWN-AI FAQ is based on asking OpenAI questions about Amesite Inc. (NASDAQ: AMST).
NASDAQ: AMST
AMST Trading
2.87% G/L:
$1.8413 Last:
541 Volume:
$1.8413 Open:
